Does the Coaching Function Improve the Learning of Mechanical In-exsufflation (MI-E) in Paediatric Subjects? (MI-Ecoaching)

The use of mechanical insufflation-exsufflation (MI-E) in children with neuromuscular diseases (NMD) is recommended by international guidelines and societies and well documented. Many authors have shown that MI-E is safe and effective for airway clearance and has a significant benefit in reducing the duration of the airway clearance session in children with respiratory infections and atelectasis or in the postoperative period. However, its use in paediatrics is still poorly supervised and learning the technique is too often therapist- and/or patient-dependent. The use of a protocol or means of help to guide the initiation and learning of MI-E would allow better use, better adaptation of the settings and potentially better compliance with the treatment. The aim of this study is to test whether the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the technique compared to guidance alone.This randomized controlled study will first include healthy children, aged 6 to 12 years, with no history or recent respiratory infection affecting lung function or other chronic diseases. In a second phase, the investigators will test the use of the learning process in children with neuromuscular diseases. The investigators hope that the results of this study will provide a better framework for the learning and effectiveness of MI-E. Furthermore, if the results are positive, this will allow better support for the use of MI-E in chronic treatments and help to ensure that this costly treatment for hospitals and public health is used efficiently.

Study Overview

Detailed Description

RATIONALE In the first part, the population will be composed of healthy children, in the second part, the investigators will include children with neuromuscular diseases. The two parts will follow the same process. The hypothesis is that the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the MI-E compared to guidance alone. The MI-E technique does not represent any documented risk in its use nor in its indication if the contraindications are respected (non-drained pneumothorax, hemoptysis and hemodynamic instability). Coaching modules (playful visual stimulation) have recently become available on MI-E devices. This experiment will allow us to judge their usefulness in teaching the use of MI-E in paediatric patients.

OBJECTIVES The aim of this study is to test whether the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the technique compared to guidance alone. This randomized controlled study will first include healthy children, aged 6 to 12 years. In a second phase, the investigators will test the use in children with neuromuscular diseases. For the process (common for the two parts), eligible subjects will be invited to perform, depending on randomization at the intervention 1 (physiotherapist guidance + coaching module) or the intervention 2 (physiotherapist guidance). The learning times, the coughing expiratory flow rate achieved and the synchronization between the subject and the machine will be compared between the two processes.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Part 1:

  • Inclusion criteria

    • Age 6-12 (F/M)
    • Acceptance of consent (child + 2 parents)
    • Non-smoker
    • Speak and understand French
    • Schooling in mainstream education
  • Exclusion criteria

    • Comorbidities: congenital heart disease, chronic lung disease, immune deficiency, neuromuscular disease, neurological disease or multiple disabilities
    • History or clinical signs of disease affecting lung function, recent lung infection, spinal or thoracic deformity.

Part 2:

  • Inclusion criteria

    • Age 6-12 (F/M)
    • Acceptance of consent (child + 2 parents)
    • Non-smoker
    • Speak and understand French
    • Patient with a neuromuscular disease
    • Able to perform the MI-E maneuver
  • Exclusion criteria

    • Hemodynamic instability
    • Current or recent pneumothorax
    • Hemoptysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Only physiotherapist guidance
The aim of this study is to test whether the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the technique compared to guidance alone.
Learning to use an in-exsufflation device with the guidance of a physiotherapist
Active Comparator: Physiotherapist guidance + coaching module
The aim of this study is to test whether the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the technique compared to guidance alone.
Learning to use an in-exsufflation device with the guidance of a physiotherapist
Learning the use of an in-exsufflation device using a coaching mode (playful visual stimulation) in addition to guidance of a physiotherapist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness
Time Frame: A the end of the learning session (after maximum 15 minutes)
The investigators will measure the number of sets (n) needed by the subjects to achieve five quality voluntary coughs during the learning session.
A the end of the learning session (after maximum 15 minutes)
Effectiveness
Time Frame: A the end of the learning (after maximum 15 minutes).
The investigators will measure the time needed (sec) by the subjects to achieve five quality voluntary coughs during the learning session.
A the end of the learning (after maximum 15 minutes).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak cough flow measured with the device (L/min)
Time Frame: During the learning session (max 15 minutes)
The peak cough flow reached with the In-exsufflation device will be reported
During the learning session (max 15 minutes)
Peak cough flow measured with the device (L/min)
Time Frame: During the session on the second day (24 hours after the learning session)
The peak cough flow reached with the In-exsufflation device will be reported
During the session on the second day (24 hours after the learning session)
Visual analog scales (VAS) "ease of use" (0-10)
Time Frame: At the end of the learning session (max 15 minutes)
Children will be assessed about the ease of the learning
At the end of the learning session (max 15 minutes)
Visual analog scales (VAS) "ease of use" (0-10)
Time Frame: At the end of the session on the second day (24 hours after the learning session)
Children will be assessed about the ease of the learning
At the end of the session on the second day (24 hours after the learning session)
Visual analog scales (VAS) "comfort" (0-10)
Time Frame: At the end of the learning session (max 15 minutes)
Children will be assessed about the comfort of the procedure
At the end of the learning session (max 15 minutes)
Visual analog scales (VAS) "comfort" (0-10)
Time Frame: At the end of the session on the second day (24 hours after the learning session)
Children will be assessed about the comfort of the procedure
At the end of the session on the second day (24 hours after the learning session)
the number of sets (n)
Time Frame: At the end of the session on the second day (24 hours after the learning session)
The investigators will measure the number of sets (n) needed by the subjects to achieve five Quality voluntary coughs one day after the first session.
At the end of the session on the second day (24 hours after the learning session)
the time (sec) needed by the subjects to achieve five Quality voluntary coughs
Time Frame: At the end of the session on the second day (24 hours after the learning session)
The investigators will measure the time (sec) needed by the subjects to achieve five Quality voluntary coughs one day after the learning session.
At the end of the session on the second day (24 hours after the learning session)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nicolas Audag, PhD, Cliniques universitaires Saint-Luc

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2023

Primary Completion (Estimated)

January 20, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

December 8, 2023

First Submitted That Met QC Criteria

January 3, 2024

First Posted (Actual)

January 5, 2024

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 3, 2024

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MI-E coaching project

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neuromuscular Diseases

Clinical Trials on Learning the use of an in-exsufflation device with the guidance of a physiotherapist

3
Subscribe